Corrigendum to "Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma" [Genomics Volume 113, Issue 5, September 2021, Pages 3439-3448].

Mannarino, Laura; Craparotta, Ilaria; Ballabio, Sara; Frapolli, Roberta; Meroni, Marina; Bello, Ezia; Panini, Nicolò; Callari, Maurizio; Sanfilippo, Roberta; Casali, Paolo G; Barisella, Marta; Fabbroni, Chiara; Marchini, Sergio; D'Incalci, Maurizio

Mannarino, Laura; Craparotta, Ilaria; Ballabio, Sara; Frapolli, Roberta; Meroni, Marina; Bello, Ezia; Panini, Nicolò; Callari, Maurizio; Sanfilippo, Roberta; Casali, Paolo G; Barisella, Marta; Fabbroni, Chiara; Marchini, Sergio; D'Incalci, Maurizio.

Afiliação

Mannarino L; Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.
Craparotta I; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Ballabio S; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Frapolli R; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Meroni M; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Bello E; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Panini N; Department of Oncology, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, via Mario Negri 2, 20156 Milan, Italy.
Callari M; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
Sanfilippo R; Adult Mesenchymal Tumour Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Casali PG; Adult Mesenchymal Tumour Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Barisella M; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Fabbroni C; Adult Mesenchymal Tumour Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
Marchini S; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.
D'Incalci M; Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy. Electronic address: maurizio.dincalci@hunimed.eu.

Genomics ; 114(1): 473, 2022 Jan.

Article em En | MEDLINE | ID: mdl-34535324

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genomics Assunto da revista: GENETICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google